4//SEC Filing
LeBel Carl 4
Accession 0001127602-22-006321
CIK 0001703647other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:36 PM ET
Size
6.8 KB
Accession
0001127602-22-006321
Insider Transaction Report
Form 4
LeBel Carl
Chief Development Officer
Transactions
- Sale
Common Stock
2022-02-18$3.87/sh−974$3,772→ 12,195 total - Sale
Common Stock
2022-02-22$3.53/sh−1,069$3,773→ 11,126 total
Footnotes (3)
- [F1]Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.80 to $3.95. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.40 to $3.73. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Documents
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001439275
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:36 PM ET
- Size
- 6.8 KB